Chlamydia pneumoniae - An infectious risk factor for atherosclerosis?

Nature Reviews Microbiology

Volumn 2, Issue 1, 2004, Pages 23-32

  Campbell, Lee Ann ^a   Kuo, Cho Cho ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; ATORVASTATIN; AZITHROMYCIN; CD31 ANTIGEN; EARLY GROWTH RESPONSE FACTOR 1; GATIFLOXACIN; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; RIFAMPICIN; ROXITHROMYCIN; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROGENESIS; ATHEROSCLEROSIS; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATION; CARDIOVASCULAR RISK; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE TRANSMISSION; GENE EXPRESSION; HUMAN; IMMUNOCYTOCHEMISTRY; MACROPHAGE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEROLOGY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ANIMAL; ARTERIOSCLEROSIS; C57BL MOUSE; CHILD; CHRONIC DISEASE; DISEASE MODEL; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOUSE; RABBIT;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDOPHILA; CHLAMYDOPHILA PNEUMONIAE;

ANIMALS; ARTERIOSCLEROSIS; CHILD; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, INBRED C57BL; RABBITS; RISK FACTORS;

EID: 1842486666     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro796     Document Type: Review

References (109)

1. Moulder, J. W., Hatch, T. P., Kuo, C.-C, Schachter, J. & Storz, J. in Bergey's Manual of Systematic Bacteriology Vol. 1 (ed. Krieg, N. R.) 729-739 (Williams and Wilkins, Baltimore, USA, 1984).
2. Grayston, J. T., Kuo, C.-C., Campbell, L. A. & Wang S.-P. Chlamydia pneumoniae sp. Nov. for Chlamydia strain TWAR. Int. J. Syst. Bacteriol. 39, 88-90 (1988).
3. Grayston, J. T. et al. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J. Infect. Dis. 168, 1231-1235 (1993).
4. Grayston, J. T. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J. Infect. Dis. 181 S402-S410 (2000).
5. Fuksuhi, H. & Hirai, K. Proposal of Chlamydia pecorum sp. nov. for Chlamydia strains derived from ruminants. Int. J. Syst. Bacteriol. 42, 306-308 (1992).
6. Wyrick P. B. et al. Entry of genital Chlamydia trachomatis into polarized human epithelial cells. Infect. Immun. 57, 2378-2389 (1989).
7. Moulder, J. W. Interaction of chlamydiae and host cells in vitro. Microbiol. Rev. 55, 143-190 (1991).
8. Kuo, C.-C. & Grayston, J. T. Interaction of Chlamydia trachomatis organisms and HeLa 229 cells. Infect. Immun. 13 1103-1109 (1976).
9. Raulston, J. E., Davis, C. H, Schmiel, D. H., Morgan, M. W. & Wyrick P. B. Molecular characterization and outer membrane association of a Chlamydia trachomatis protein related to the hsp70 family of proteins. J. Biol. Chem. 268, 23139-23147 (1993).
10. Su, H., Watkins, N. G., Zhang, Y. X. & Caldwell, H. D. Chlamydia trachomatis-host cell interactions: role of the chlamydial major outer membrane protein as an adhesin. Infect. Immun. 58 1017-1025 (1990).
11. Zhang, J. P. & Stephens, R. S. Mechanism of C. trachomatis attachment to eukaryotic host cells. Cell 69, 861-889 (1992).
12. Chen, C. & Stephens, R. S. Chlamydia trachomatis glycosaminoglycan-dependent and independent attachment to eukryotic cells. Microb. Pathogen. 22, 23-30 (1997).
13. Kuo C.-C., Takahashi, N., Swanson, A. F., Ozeki, Y. & Hakomori, S.-I. An N-linked high-mannose type oligosaccharide, agressed at the major outer membrane protein of Chlamydia trachomatis, mediates attachment and infectivity of the microorganism to HeLa cells. J. Clin. Invest. 98, 2813-2818 (1996).
14. Kuo, C.-C., Puolakkainen, M., Lin, T.-M., Witte, M. & Campbell, L. A. Mannose-receptor positive and negative mouse macrophages differ in their susceptibility to infection by Chlamydia species. Microb. Pathogen. 32, 43-48 (2002).
15. Wuppermann, F. N., Hegemann, J. H. & Jantos, C. A. Heparan sulfate-like glycosaminoglycan is a cellular receptor for Chlamydia pneumoniae. J. Infect. Dis. 184, 181-187 (2001).
16. Nicholson, T. L., Olinger, L., Chong, K., Schoolnik G. & Stephens, R. S. Global stage-specific gene regulation during the developmental cycle of Chlamydia trachomatis. J. Bacteriol. 185 3179-3189 (2003).
17. Xi, M., Bumgarner, R. E., Lampe, M. F. & Stamm, R. E. Chlamydia trachomatis infection alters host cell transcription in diverse cellular pathways. J. Infect. Dis. 187, 424-434 (2003).
18. Dwyer, R., Treharne, J. D., Jones B. R. & Herring, J. Chlamydial infection. Results of micro-immunoflourescence tests for the detection of type specific antibody in certain chlamydial infections. Br. J. Vener. Dis. 56, 404-407 (1972).
19. Kuo, C.-C., Jackson, L. A., Campbell, L. A. & Grayston, J. T. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8, 451-461 (1995).
20. Wang, S.-P. & Grayston, J. T. in Chlamydial infections (eds Oriel, D., Ridgway, G., Schacter, J., Taylor-Robinson, D & Ward, M.) 329-332 (Cambridge Univ. Press, UK, 1986).
21. Kuo, C.-C., Chen, H.-H., Wang, S.-P. & Grayston, J. T. Identification of a new group of Chlamydia psittaci strains called TWAR. J. Clin. Microbiol. 24, 1034-1037 (1986).
22. Murray, C. J. L. & Lopez, L. D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349 1269-1276 (1997).
23. Ross, R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340, 115-126 (1998).
24. Lusis, A. J. Atherosclerosis. Nature 407, 233-241 (2000).
25. Hogg N. & Berlin, C. Structure and function of adhesion receptors in leukocyte trafficking. Immunol. Today 16, 327-334 (1995).
26. Poston, R. N., Haskard, D. O., Coucher, J. R. & Gall, M. N. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am. J. Pathol. 140, 665-673 (1992).
27. Johnson-Tidey, R. R., McGregor, J. L., Taylor, P. R. & Poston, R. N. Increase in adhesion molecule P-selectin in endothelium overlaying atherosclerotic plaques: coexpression with intercellular adhesion molecule-1. Am. J. Pathol. 144, 952-961 (1994).
28. Cybulsky, M. I. & Gimbrone, M. A. Jr. Endothelial expression of a monocuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788-791 (1994).
29. Iiyama, K. et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ. Res. 85, 199-207 (1999).
30. Muller W. A. et al. PECAM-1 required for transendothelial migration of leukocytes. J. Exp. Med. 178, 449-460 (1993).
31. O'Connor, S., Taylor, C., Campbell, L. A., Espstein, S. & Libby, P. Potential infectious etiologies of atherosclerosis. A multifactorial perspective. Emerg. Infect. Dis. 7, 780-788 (2001).
32. Ngeh, J., Anand, V. &. Gupta, S. Chlamydia pneumoniae and atherosclerosis - what we know and what we don't. Clin. Microbiol. Infect. 8, 2-13 (2002).
33. Fabricant, C. G., Fabricant, J., Litrenta, M. M. & Minick, C.R. Virus-induced atherosclerosis. J. Exp. Med. 148, 335-340 (1978).
34. Fabricant, C. G., Fabricant, J., Minick, C. R. & Litrenta, M. M. Herpesvirus-induced atherosclerosis in chickens. Fed. Proc. 42, 2476-2479 (1983).
35. Wang, S. P. & Grayston, J. T. in Chlamydial Infections (eds Stephen, R. S. et al.) 155-158. (University of California, Berkeley, California, 1998).
36. Saikku, P. et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2, 983-986 (1988).
37. Kuo, C.-C. & Campbell, L. A. Chlamydial infection of the cardiovascular system. Front. Biosci. 8, e36-e42 (2003).
38. Peeling, R. W. et al. Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. J. Infect. Dis. 181, S426-S429 (2000).
39. Shor, A., Kuo, C. C. & Patton, D. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and etheromatous plaques. S. Afr. Med. J. 82, 158-161 (1992).
40. Kuo, C.-C., et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis. 167, 841-849 (1993).
41. Kuo, C.-C. & Campbell, L. A. Detection of Chlamydia pneumoniae in arterial tissues. J. Infect. Dis. 181, S432-S436 (2000).
42. Taylor-Robinson, D. & Thomas, B. J. Chlamydia pneumoniae in atherosclerotic tissue. J. Infect. Dis. 181, S437-S443 (2000).
43. Ramirez, J. et al. Isolation of Chlamydia pneumoniae (Cpn) from the coronary artery of a patient with coronary atherosclerosis. Ann. Int. Med. 125, 979-982 (1996).
44. Jackson, L., Campbell, L. A., Kuo, C.-C., Lee, A. & Grayston, J. T. Isolation of Chlamydia pneumoniae from a carotid endarctarterectomy specimen. J. Infect. Dis. 176 292-295 (1997).
45. Maass, M. et al. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J. Am. Coll. Cardiol. 31, 827-832 (1998).
46. Kuo, C.-C., Gown, A. M., Benditt, E. P. & Grayston, J. T. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler. Thromb. 13, 1501-1504 (1993).
47. Ouchi, K. et al. Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic tissue. J. Infect. Dis. 181, S441-S443 (2000).
48. Puolakkainen, M., Kuo, C.-C., Wang S.-P., Grayston, J. T. & Campbell, L. A. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J. Clin. Microbiol. 31 2212-2214 (1993).
49. Maass, M., Geiffers, J., Krausa, E. & Engel, P. M. Poor correlation between microimmunofluorescence serology and polymerase chain motion for detection of vascular Chlamydia pneumoniae infection CAD patients. Med. Microbiol. Immunol. 187, 103-106 (1998).
50. Boman J. et al. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J. Infect. Dis. 178, 274-277 (1998).
51. Smieja, M., Mahony, J., Petrich, A., Boman, J. & Chernesky, M. Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review. BMC Infect. Dis. 2 21 (2002).
52. Grayston, J. T., Wang, S.-P., Yeh, L.-L. & Kuo, C.-C. Importance of reinfection in the pathogenesis of trachoma. Rev. Infect. Dis. 7, 717-725 (1985).
53. Godzik, K., O'Brien, E. R., Wang, S.-P. & Kuo, C. C. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J. Clin. Microbiol. 33, 2411-2414 (1995).
54. Gaydos, C. A., Summersgill, J. T., Sahney, N. N., Ramierez, J. A. & Quinn, T. C. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect. Immun. 64, 1614-1620 (1996).
55. Lin, T.-M., Campbell, L. A., Rosenfeld, M. E. & Kuo, C.-C. Monocyte-endothelial cell coculture enchances infection of endothelial cells with Chlamydia pneumoniae. J. Infect Dis. 181, 1096-1100 (2000).
56. Puolakkainen, M. et al. Cell-to-cell contact of human monocytes with infected arterial smooth-muscle cells enhances growth of Chlamydia pneumoniae. J. Infect. Dis. 187, 435-440 (2003).
57. Kalayoglu, M. V., Perkins, B. N. & Bryne, G. I. Chlamydia pneumoniae-infected monocytes exhibited increased adherence to human aortic endothelial cells. Microbe. Infect. 3, 963-969 (2001).
58. Kaukoranta-Rolvanen, S. S., Ronni, T., Leinonen, M., Saikku, P. & Laitinen, K. Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae. Microb. Pathog. 21, 407-411 (1996).
59. Coombes, B. K. & Mahony, J. B. cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection. Infect. Immun. 69, 1420-1427 (2001).
60. Coombes, B. K., Chiu, B., Fong, I. W. & Mahony, J. B. Chlamydia pneumoniae infection of endothelial cells induces transcriptional activation of platelet-dervied growth factor: a potential link to intimal thickening in a rabbit model of atherosclerosis. J. Infect. Dis. 185, 1621-1630 (2002).
61. Heinemann, M., Susa, M., Simnacher, U., Marre, R. & Essig, A. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect. Immun. 64, 4872-4875 (1996).
62. Summmersgill, J. T., Molestina, R. E., Miller, R. D. & Ramirez, J. A. Interactions of Chlamydia pneumoniae with human endothelial cells. J. Infect. Dis. 181, S479-S482 (2000).
63. Kol, A., Bourcier, T., Lichtman, A. H. & Libby, P. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J. Clin. Invest. 103, 571-577 (1999).
64. Dechend, R. et al. Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae induced cell interaction and activation. Circulation 108, 261-265 (2003 ).
65. Kothe, H. et al. Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae. Circulation 101, 1760-1763 (2000).
66. Kalayoglu, M. V. & Byrne, G. I. Unduction of macrophage foam-cell formation by Chlamydia pneumoniae J. Infect. Dis. 177 725-729 (1998).
67. Kalayoglu, M. V. et al. Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions. J. Infect. Dis., 181, S483-S489 (2000).
68. Blessing, E. et al. Foam cell inhibits growth of Chlamydia pneumoniae but does not attenuate Chlamydia pneumoniae induced secretion of pro-inflammatory cytokines. Circulation 105 1976-1982 (2002).
69. Choi, E. Y. et al. Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: The potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis. Exp. Mol. Med. 31, 391-400 (2002).
70. Kol, A., Sukhova, G. K., Lichtman, A. H. & Libby, P. Chlamydial heat shock protein 60 localized in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression. Circulation 98, 300-307 (1998).
71. Bea, F. et al. Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK 1/2 pathway. Circ. Res. 92, 394-401 (2003).
72. Fryer, R. H., Schwobe, E. P., Woods, M. L. & Rogers, G. M. Chlamydia species infect human vascular endothelial cells and home procoagulant activity. J. Investig. Med. 45, 168-174 (1997 ).
73. Dechend, R. et al. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation 100, 1369-1373 (1999).
74. McCaffrey, T. A. et al. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human athersoclerosis. J. Clin. Invest. 105, 653-662 (2000).
75. Silverman, E. S. & Collins, T. Pathways of Egr-1-mediated gene transcription in vascular biology. Am. J. Pathol. 154, 665-670 (1999).
76. Reddick, R. L., Zhang, S. H. & Maeda, N. Atherosclerosis in mice lacking apoE. Arterioscler. Thromb. 4, 141-147 (1994).
77. Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L. & Ross. R. ApoE deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14, 133-140 (1994).
78. Moazed, T. C., Kuo, C.-C., Grayston, J. T. & Campbell, L. A. Evidence of systemic dissemination of C. pneumoniae infection via macrophages in the mouse. J. Infect. Dis. 177, 132-135 (1998).
79. Moazed, T. C., Kuo, C.-C., Grayston, J. T. & Campbell, L. A. Murine models of C. pneumoniae infection and atherosclerosis. J. Infect. Dis. 175, 883-890 (1997).
80. Jackson, L. A. et al. Specificity of detection of Chlamydia pneumoniae in cardiovascular and non-cardiovascular tissues: evaluation of the innocent bystander hypothesis. Am. J. Pathol. 150, 1785-1790 (1997).
81. Grõnhagen-Riska, C., Saikku, P., Riska, H., Froseth, B. & Grayston, J. T. In Sarcoidosis and Other Granulomatous Disorders (eds Grassi, C., Rizzato, G. & Pozzi, E.) 297-301 (Excerpta Medicine, Amsterdam, Holland, 1988).
82. Puolakkainen, M. et al. Serological response to Chlamydia pneumoniae in patients with sarcoidosis. J. Infect. 33, 199-205 (1996).
83. Moazed, T. C., Campbell, L. A., Rosenfeld, M. E., Grayston, J. T. & Kuo, C.-C. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J. Infect. Dis. 180, 238-241 (1999).
84. Rothstein, N. M., Quinn, T. C., Madico, G., Gaydos, C. A. & Lowenstein, C. J. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamdyia pneumoniae. J. Infect. Dis. 183, 232-238 (2001).
85. Burnett, M. S. et al. Atherosclerosis in apoE knockout mice infected with multiple pathogens. J. Infect. Dis. 183, 226-231 (2001).
86. Hu, H., Pierce, G. N. &. Zhong, G. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J. Clin. Invest. 103, 747-753 (1999).
87. Blessing, E., Campbell, L. A., Rosenfeld, M. E. & Kuo, C.-C. Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice. Atherosclerosis 158, 13-17 (2001).
88. Muhlestein, J. B. et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 97, 633-636 (1998).
89. Fong, I. W., Chiu, B., Viira, E., Jang, D. & Mahoney, J. B. Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model. Antimicrob. Agents Chemother. 46, 2321-2326 (2002).
90. Caligiuri, G., Rottenberg, M., Nicoletti, A., Wigzell, H. & Hansson, G. K. Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation 103, 2834-2838 (2001).
91. Aalto-Setala, K. et al. Chlamdyia pneumoniae does not increase atherosclerosis in the aortic root of apolipprotein E-deficient mice. Arteroscler. Thromb. Vasc. Biol. 21, 578-584 (2001).
92. Blessing, E. et al. Chlamdyia pneumoniae induces inflammatory changes in the heart and aorta of normolipidemic C57BL/6J mice. Infect. Immun. 68, 4765-4768 (2000).
93. Laitinen, K., Laurila, A., Pyhala, L., Leinonen, M. & Saikku, P. Chlamydia pneumoniae infection induces inflammatory changes in the aorta of rabbits. Infect. Immun. 65, 4832-4835 (1997).
94. Fong, I. W. et al. De novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model. Infect. Immun. 67, 648-655 (1999)
95. Blessing, E., Campbell, L. A., Rosenfeld, M. E. & Kuo, C.-C. Chlamydia pneumoniae and hyperlipidemia are co-risk factors for atherosclerosis: infection prior to induction of hyperlipidemia does not accelerate development of atherosclerotic lesions in C57BL/6J mice. Infect. Immun. 70, 5332-5334 (2002).
96. Pislaru, S. V. et al. Chlamydia pneumoniae induces neointima formation in coronary arteries of normal pigs. Cardiovas. Res. 57, 834-843 (2003).
97. Liuba, P. et al. Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice. Circulation 102, 1039-1044 (2000).
98. Liuba, P. et al. Acute Chlamydia pneumoniae infection causes coronary endothelial dysfunction in pigs. Atherosclerosis 167, 215-222 (2003).
99. Kuvin, J. T. et al. Effect of short-term antibiotic treatment on Chlamydia pneumoniae and peripheral endothelial function. Am. J. Cardiol. 91, 732-735 (2003).
100. Ezzahiri, R. et al. . Chlamydia pneumoniae infection induces and unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE douple knockout mice. Eur. J. Vasc. Endovasc. Surg. 26, 88-95 (2003)
101. Malinverni, R., Kuo, C.-C., Campbell, L. A., Lee, A. & Grayston J. T. Experimental Chlamydia pneumoniae (TWAR) pneumonitis: affect of two antibiotic regimens on the course and persistence of infection. Antimicrob. Agents. Chemother. 39, 45-49 (1995).
102. Fong, I. W. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis. J. Infect. Dis. 181, S514-S518 (2000).
103. Grayston, J. T. Antibiotic treatment of atherosclerotic cardiovascular disease. Circulation 107, 1228-1230 (2003).
104. O'Connor, C. M. et al. Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA 290, 1459-1466 (2003).
105. Beatty, W., Morrison, R. P. & Byrne, G. I. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microb. Rev. 58, 686-699 (1994).
106. Gieffers, J. et al. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 103, S1-S6 (2001).
107. Campbell, L. A., Marrazzo, J. M., Stamm, W. E. & Kuo, C.-C. in Laboratory Diagnosis of Bacterial Infections. (ed. Cimolai, N.) 795-821 (Marcel Dekker, New York, 2001).
108. Kuo, C.-C. et al. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc. Natl Acad. Sci. USA 92, 6911-6914 (1995).
109. Kalayoglu, M. V., Libby, P. & Byrne, G. I. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA 288, 2724-2731 (2002).